This suggests that alterations in DNA damage‐ and repair‐related genes resulting from Notch1 mutations could account for the differential mutational load [21], and the heterogeneity observed in mutational signatures across various tumor subtypes sheds light on their origin, clinical evolution, and potential therapeutic sensitivities [23]. Here, NOTCH1 is linked to neoplasm.